Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
57
CTS Quote, Financials, Valuation and Earnings
Last price:
$41.93
Seasonality move
:
1.95%
Day range:
$40.93 - $41.66
52-week range:
$34.02 - $59.68
Dividend yield:
0.39%
P/E ratio:
20.96x
P/S ratio:
2.46x
P/B ratio:
2.31x
Volume:
327.1K
Avg. volume:
178.2K
1-year change:
-24.46%
Market cap:
$1.2B
Revenue:
$515.8M
EPS (TTM):
$1.98
Analysts' Opinion
-
Consensus RatingCTS has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $43.00, CTS has an estimated upside of 3.62% from its current price of $41.50.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $43.00 representing 100% downside risk from its current price of $41.50.
Fair Value
-
According to the consensus of 1 analyst, CTS has 3.62% upside to fair value with a price target of $43.00 per share.
CTS vs. S&P 500
-
Over the past 5 trading days, CTS has underperformed the S&P 500 by -4.15% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
CTS does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CTS has grown year-over-year revenues for 2 quarters straight. In the most recent quarter CTS reported revenues of $125.8M.
Earnings Growth
-
CTS has grown year-over-year earnings for 1 quarter straight. In the most recent quarter CTS reported earnings per share of $0.44.
Enterprise value:
1.2B
EV / Invested capital:
--
Price / LTM sales:
2.46x
EV / EBIT:
15.86x
EV / Revenue:
2.41x
PEG ratio (5yr expected):
1.27x
EV / Free cash flow:
16.04x
Price / Operating cash flow:
16.38x
Enterprise value / EBITDA:
11.25x
Gross Profit (TTM):
$190.6M
Return On Assets:
7.99%
Net Income Margin (TTM):
11.7%
Return On Equity:
11.42%
Return On Invested Capital:
9.87%
Operating Margin:
13.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $585.2M | $530.2M | $515.8M | $125.8M | $125.8M | |
| Gross Profit | $207.9M | $184.3M | $190.6M | $45.1M | $46.5M | |
| Operating Income | $91.6M | $75.3M | $78M | $16.2M | $16.7M | |
| EBITDA | $110M | $98.7M | $110.4M | $21.8M | $25.8M | |
| Diluted EPS | $1.81 | $1.70 | $1.98 | $0.36 | $0.44 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $246.6M | $292M | $322.6M | $318.2M | $243.5M | |
| Total Assets | $634.7M | $684.7M | $747M | $732.8M | $765.5M | |
| Current Liabilities | $106.7M | $115M | $105.8M | $95.9M | $92.4M | |
| Total Liabilities | $198.9M | $204.6M | $232.9M | $211.6M | $227.3M | |
| Total Equity | $435.7M | $480.2M | $514.1M | $521.3M | $538.2M | |
| Total Debt | $50M | $50M | $80.3M | $67.5M | $86.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $113.1M | $95.9M | $96.5M | $18.3M | $15.5M | |
| Cash From Investing | -$91.2M | -$14.2M | -$141M | -$4M | -$4.5M | |
| Cash From Financing | -$5.5M | -$65.1M | -$27.5M | -$16.3M | -$15.9M | |
| Free Cash Flow | $97.6M | $81.7M | $77.4M | $14.3M | $11.1M | |
CTS
Sector
Market Cap
$1.2B
$83.5M
Price % of 52-Week High
69.54%
64.2%
Dividend Yield
0.39%
0%
Shareholder Yield
3.05%
0.68%
1-Year Price Total Return
-24.46%
-12.88%
Beta (5-Year)
0.804
0.814
Dividend yield:
0.39%
Annualized payout:
$0.16
Payout ratio:
8.04%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$42.31
200-day SMA
Sell
Level
$46.41
Bollinger Bands (100)
Buy
Level
39.14 - 43.76
Chaikin Money Flow
Buy
Level
9.6M
20-day SMA
Sell
Level
$42.66
Relative Strength Index (RSI14)
Sell
Level
44.40
ADX Line
Sell
Level
12.28
Williams %R
Buy
Level
-86.7359
50-day SMA
Sell
Level
$41.91
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Neutral
Level
7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.4638)
Buy
CA Score
(Annual)
Level (1.1809)
Buy
Beneish M-Score
(Annual)
Level (-2.7131)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.5908)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.
Stock Forecast FAQ
In the current month, CTS has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CTS average analyst price target in the past 3 months is $43.00.
-
Where Will CTS Stock Be In 1 Year?
According to analysts, the consensus estimate is that CTS share price will rise to $43.00 per share over the next 12 months.
-
What Do Analysts Say About CTS?
Analysts are divided on their view about CTS share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CTS is a Sell and believe this share price will drop from its current level to $43.00.
-
What Is CTS's Price Target?
The price target for CTS over the next 1-year time period is forecast to be $43.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CTS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CTS is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of CTS?
You can purchase shares of CTS via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CTS shares.
-
What Is The CTS Share Price Today?
CTS was last trading at $41.93 per share. This represents the most recent stock quote for CTS. Yesterday, CTS closed at $41.50 per share.
-
How To Buy CTS Stock Online?
In order to purchase CTS stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
